HIV-TAT INCREASES IL-6 PRODUCTION BY AND PROLIFERATION OF AIDS-KS DERIVED CELLS (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV-TAT INCREASES IL-6 PRODUCTION BY AND PROLIFERATION OF AIDS-KS DERIVED CELLS (MEETING ABSTRACT)

Proc Annu Meet Am Soc Clin Oncol; 10:A6 1991. Unique Identifier : AIDSLINE ICDB/91671338
Rezai A; Martinez-Maza O; Gaynor R; Kishimoto T; Hirano T; Mitsuyasu RT; Miles SA; UCLA AIDS Center, Los Angeles, CA 90024-1793


Abstract: AIDS-related Kaposi's sarcoma (AIDS-KS) is a multifocal proliferation of cells commonly observed in patients infected with human immunodeficiency virus (HIV). Previous studies suggested that the AIDS-KS spindle cells are of endothelial origin, produce multiple cytokines which have autocrine and paracrine growth properties, and proliferate in response to the transactivating protein of HIV, HIV-tat. We showed that AIDS-KS tissue produces large amounts of immunoreactive interleukin-6 (IL-6) and that AIDS-KS derived cell lines produce and respond to IL-6 in an autocrine growth loop. We investigated the effects of HIV-tat on IL-6 production by and proliferation of AIDS-KS derived cell lines. We found that IL-6 production by AIDS-KS cells can be increased by exposure to recombinant HIV-tat protein or by transfection of an HIV-tat expression vector. A control nonfunctional mutated HIV-tat expression vector had no effect. The increase in IL-6 production which was observed is accompanied by corresponding increases in cellular proliferation in the four cell lines examined. The increases in IL-6 production and proliferation of KS cells was inhibited by antisense but not sense IL-6 oligonucleotide polymers. No direct transactivation of the 5' flanking sequences of the IL-6 gene was found after cotransfection with HIV-tat in AIDS-KS derived cells. Our data suggests that HIV-tat increases IL-6 production by its KS cells, and this is associated with increased cell proliferation. The effects of HIV-tat on IL-6 production is presumably indirect as no direct effects on IL-6 gene regulatory elements were found.
Keywords: Acquired Immunodeficiency Syndrome/*PATHOLOGY Cell Division/*PHYSIOLOGY Cell Line Gene Products, tat/*PHYSIOLOGY Human Interleukin-6/*BIOSYNTHESIS Sarcoma, Kaposi's/*PATHOLOGY Tumor Cells, Cultured/*PATHOLOGY ABSTRACT

KWDacquiredimmunodeficiencysyndrome/KWDpathologycelldivision/KWDphysiologycelllinegeneproducts,tat/KWDphysiologyhumaninterleukin-6/KWDbiosynthesissarcoma,kaposi's/KWDpathologytumorcells,cultured/KWDpathologyabstract
910830
M9181011


Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .